Skip to main content

Nonprofit · EIN 36-4433410

LUNGEVITY FOUNDATION

Tax-exempt · CHICAGO, IL 60604

Financials

$14.4M$18.4M2022$13.8M$15.9M2023$14.2M$14.6M2024
Revenue Expenses · by fiscal year end
Financials of LUNGEVITY FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$14,237,969$14,555,858-$317,889$6,169,133$956,735$5,212,398
June 30, 2024990$13,750,114$15,901,116-$2,151,002$6,220,479$690,192$5,530,287
June 30, 2023990$14,391,489$18,403,410-$4,011,921$8,760,023$1,078,734$7,681,289
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$14,627,477
Program service revenue
$0
Investment income
$36,657
Net gain from sales of assets
$35,945
Net income from fundraising events
-$426,165
Other revenue
-$426,165

Expenses

Grants and similar amounts paid
$4,259,119
Compensation of officers, directors and key employees
$483,856
Other salaries and wages
$4,589,994
Salaries, compensation and benefits (total)
$6,406,047
Professional fundraising fees
$0
Legal fees
$11,633
Accounting fees
$43,600
Occupancy
$261,918
Travel
$344,324
Depreciation
$6,666
Program services (functional)
$12,385,425
Management and general (functional)
$690,870
Fundraising (functional)
$1,479,563

Balance sheet and other

Total assets, start of year
$6,220,479
Total assets, end of year
$6,169,133
Total liabilities, end of year
$956,735
Net assets, end of year
$5,212,398
Net assets without donor restrictions
$1,125,185
Net assets with donor restrictions
$4,087,213
Gross receipts
$16,000,740
Employees
60
Volunteers
200
Year formed
2001
State of legal domicile
IL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
UPAL BASU ROYEXECUTIVE DIRECTOR OF RESEARCH
Highest-paid employee
40$214,132$21,276
MERIAM DRISSEVP, STRATEGY & BUSINESS DEVELOPMENT
Highest-paid employee
40$179,371$36,057
NICOLE MARTINDIR OF PRECISION MEDICINE
Highest-paid employee
40$172,107$30,304
WENDY KLEINCHIEF STRATEGY OFFICER
Officer
40$183,750$18,252
AMY MOOREVP GLOBAL ENGAGEMENT & PARTNERSHIPS - TERM
Highest-paid employee
40$184,843$1,024
ANDREA STERN FERRISPRESIDENT & CEO
Trustee or director, Officer
40$140,525$33,700
LEAH FINEVP, EARLY LUNG CANCER CENTER
Highest-paid employee
40$152,500$16,171
LYNNE DOUGHTIECHAIRMAN
Trustee or director, Officer
2$0$0
NICHELLE STIGGERSECRETARY
Trustee or director, Officer
2$0$0
ALEX STERNTREASURER
Trustee or director, Officer
2$0$0
JASON BERNARDDIRECTOR
Trustee or director
2$0$0
TERRI ANN DIJULIODIRECTOR
Trustee or director
2$0$0
BJ JONESDIRECTOR
Trustee or director
2$0$0
JENNIFER KASHATUSDIRECTOR
Trustee or director
2$0$0
MICHAEL KOLODZIEJDIRECTOR
Trustee or director
2$0$0
10 more people on this return
NameTitleHours / weekCompensation
MICHAEL MARQUISDIRECTOR
Trustee or director
2$0
BARRY NELSONDIRECTOR
Trustee or director
2$0
ROBERT NEWMANDIRECTOR
Trustee or director
2$0
ANDRE OWENSDIRECTOR
Trustee or director
2$0
MICHAEL PARISIDIRECTOR
Trustee or director
2$0
DR CHARLES RUDINDIRECTOR
Trustee or director
2$0
FRANK SIERAWSKIDIRECTOR
Trustee or director
2$0
ANDREW STERNDIRECTOR
Trustee or director
2$0
PAUL G STERNDIRECTOR
Trustee or director
2$0
DR ROBERT WINN MDDIRECTOR
Trustee or director
2$0
990 for the year ended June 30, 2024: 23 people
NameTitleHours / weekCompensationOther / benefits
ANDREA STERN FERRISPRESIDENT & CEO
Trustee or director, Officer
40$244,371$35,252
UPAL BASU ROYEXECUTIVE DIRECTOR OF RESEARCH
Highest-paid employee
40$214,132$23,705
LINDA WENGERCHIEF MARKETING OFFICER - TERM
Officer
40$183,882$21,752
WENDY KLEINCHIEF STRATEGY OFFICER
Officer
40$183,750$20,903
NICOLE MARTINDIR OF PRECISION MEDICINE
Highest-paid employee
40$168,107$32,372
MERIAM DRISSEVP, STRATEGY & BUSINESS DEVELOPMENT
Highest-paid employee
40$149,525$38,355
AMY MOOREVP GLOBAL ENGAGEMENT & PARTNERSHIPS
Highest-paid employee
40$183,750$0
MALONA FISH-STEAGALLSR VP, PATIENT SERVICES
Highest-paid employee
40$146,958$24,496
REBECCA BULLCHIEF DEVELOPMENT OFFICER - TERM
Officer
40$67,146$3,421
LYNNE DOUGHTIECHAIRMAN
Trustee or director, Officer
2$0$0
NICHELLE STIGGERSECRETARY
Trustee or director, Officer
2$0$0
ALEX STERNTREASURER
Trustee or director, Officer
2$0$0
TOM GALLITREASURER - TERM
Trustee or director, Officer
2$0$0
BJ JONESDIRECTOR
Trustee or director
2$0$0
JENNIFER KASHATUSDIRECTOR
Trustee or director
2$0$0
MICHAEL KOLODZIEJDIRECTOR
Trustee or director
2$0$0
MICHAEL MARQUISDIRECTOR
Trustee or director
2$0$0
ANDRE OWENSDIRECTOR
Trustee or director
2$0$0
MICHAEL PARISIDIRECTOR
Trustee or director
2$0$0
DR CHARLES RUDINDIRECTOR
Trustee or director
2$0$0
ANDREW STERNDIRECTOR
Trustee or director
2$0$0
PAUL G STERNDIRECTOR
Trustee or director
2$0$0
ROBERT WINNDIRECTOR
Trustee or director
2$0$0
990 for the year ended June 30, 2023: 24 people
NameTitleHours / weekCompensationOther / benefits
ANDREA STERN FERRISPRESIDENT & CEO
Trustee or director, Officer
40$244,371$34,117
BARBARA NETTERCOO & CFO - TERM
Officer
40$206,688$36,772
UPAL BASU ROYEXECUTIVE DIRECTOR OF RESEARCH
Highest-paid employee
40$208,612$24,555
REBECCA BULLCHIEF DEVELOPMENT OFFICER
Officer
40$173,410$31,932
WENDY KLEINCHIEF STRATEGY OFFICER
Officer
40$179,039$22,001
LINDA WENGERCHIEF MARKETING OFFICER
Officer
40$178,497$22,331
NICOLE MARTINDIR OF PRECISION MEDICINE
Highest-paid employee
40$162,565$32,676
AMY MOOREVP GLOBAL ENGAGEMENT & PATIENT PSHPS
Highest-paid employee
40$179,039$0
MERIAM DRISSVP OF STRATEGIC PSHPS
Highest-paid employee
40$127,371$36,777
CAROL PERLINEVP OF PHILANTHROPY
Highest-paid employee
40$117,345$40,136
ALEX STERNCHAIRMAN
Trustee or director, Officer
2$0$0
NICHELLE STIGGERSECRETARY
Trustee or director, Officer
2$0$0
TOM GALLITREASURER
Trustee or director, Officer
2$0$0
LYNNE DOUGHTIEDIRECTOR
Trustee or director
2$0$0
BJ JONESDIRECTOR
Trustee or director
2$0$0
JENNIFER KASHATUSDIRECTOR
Trustee or director
2$0$0
MICHAEL KOLODZIEJDIRECTOR
Trustee or director
2$0$0
MICHAEL MARQUISDIRECTOR
Trustee or director
2$0$0
ANDRE OWENSDIRECTOR
Trustee or director
2$0$0
MICHAEL PARISIDIRECTOR
Trustee or director
2$0$0
DR CHARLES RUDINDIRECTOR
Trustee or director
2$0$0
ANDREW STERNDIRECTOR
Trustee or director
2$0$0
PAUL G STERNDIRECTOR
Trustee or director
2$0$0
ROBERT WINNDIRECTOR
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
332 S MICHIGAN AVE STE 900, CHICAGO, IL 60604-4393
Principal officer (990 for 2024)
ANDREA STERN FERRIS, 332 S MICHIGAN AVE SUITE 900, CHICAGO, IL 60604
Signed the 990
ANDREA STERN FERRIS, PRESIDENT & CEO
Phone
(312) 407-6100
Return prepared by
CITRIN COOPERMAN ADVISORS LLC

Mission

LUNGEVITY'S VISION IS A WORLD WHERE NO ONE DIES OF LUNG CANCER. LUNGEVITY FOUNDATION IS FIRMLY COMMITTED TO MAKING AN IMMEDIATE IMPACT ON INCREASING QUALITY-OF-LIFE AND SURVIVORSHIP OF PEOPLE WITH LUNG CANCER BY ACCELERATING RESEARCH INTO EARLY DETECTION AND MORE EFFECTIVE TREATMENTS, AS WELL AS PROVIDING COMMUNITY, SUPPORT AND EDUCATION FOR ALL THOSE AFFECTED BY THE DISEASE. BY KEEPING PATIENTS AT THE CENTER OF ALL WE DO, WE ARE TRANSFORMING LUNG CANCER AND MAKING PROGRESS EVERY SINGLE DAY.LUNGEVITY MOVES FORWARD FIRMLY RESOLVED TO PROVIDE THE ENERGY, INSPIRATION, AND RESOURCES THAT ARE CRITICAL TO MAKING LUNG CANCER A NATIONAL PRIORITY. LUNGEVITY IS A RESPONSIBLE STEWARD OF YOUR DONATION, SPENDING IT TO TRANSFORM LUNG CANCER.

990 for the year ended June 30, 2025

Program accomplishments

  • RESEARCH SERVICES - FUNDING CLINICAL RESEARCH AWARDS IN LUNG CANCER TO BRING ADVANCES IN CLINICAL RESEARCH MORE RAPIDLY TO PATIENT CARE.
    Expenses $5,359,739 · grants $4,108,540
  • PATIENT AND PUBLIC EDUCATION - CREATES, UPDATES AND MAINTAINS A COLLECTION OF EDUCATIONAL TOOLS AND MATERIALS FOR PATIENTS, CAREGIVERS, AND HEALTHCARE PROFESSIONALS.
    Expenses $3,474,079
  • IMPROVING ACCESS TO CARE - WORKS TO IMPROVE ACCESS TO LIFE-SAVING CARE IN UNDERSERVED COMMUNITIES THROUGH VARIOUS INITIATIVES, INCLUDING EFFORTS TO STREAMLINE THE CLINICAL TRIAL PROCESS AND MAKE IT MORE ACCESSIBLE TO PATIENTS, AND ENSURING BIOMARKER TESTING IS AVAILABLE TO ALL PATIENTS DIAGNOSED WITH NON-SMALL CELL LUNG CANCER.
    Expenses $2,168,425 · grants $150,579
  • SUPPORT SERVICES - OFFERS THE LARGEST ONLINE NETWORK OF SUPPORT AND IN-PERSON SURVIVORSHIP PROGRAMS FOR ALL PEOPLE AFFECTED BY LUNG CANCER, INCLUDING MESSAGE BOARDS, PEER-TO-PEER SUPPORT MATCHING SERVICE, AND NATIONAL SURVIVOR SUMMITS.
    Expenses $1,383,182

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
36-4433410
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2001
Accounting year ends
June
Files
Form 990 or 990-EZ
Assets (IRS master file)
$6,169,133
Income (IRS master file)
$16,000,740

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$14,237,969$14,555,858$6,169,133XML
990June 2024$13,750,114$15,901,116$6,220,479XML
990June 2023$14,391,489$18,403,410$8,760,023XML
990June 2022–––IRS
990June 2021–––IRS
990June 2020–––IRS
990June 2019–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 36-4433410).

Questions about LUNGEVITY FOUNDATION

What is the EIN of LUNGEVITY FOUNDATION?
The employer identification number (EIN) of LUNGEVITY FOUNDATION is 36-4433410.
Is LUNGEVITY FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2001.
Are donations to LUNGEVITY FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does LUNGEVITY FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of LUNGEVITY FOUNDATION due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did LUNGEVITY FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of LUNGEVITY FOUNDATION?
The 990 for the year ended June 30, 2025 names ANDREA STERN FERRIS.
Who are the officers and directors of LUNGEVITY FOUNDATION?
The 990 for the year ended June 30, 2025 lists 25 people; 7 received compensation from the organization, the highest $214,132 (UPAL BASU ROY, EXECUTIVE DIRECTOR OF RESEARCH).
How much revenue does LUNGEVITY FOUNDATION have?
On its 990 for the year ended June 30, 2025 it reported revenue of $14,237,969, expenses of $14,555,858 and total assets of $6,169,133 at year end.

Other nonprofits in CHICAGO

All nonprofits in CHICAGO · Illinois · Medical research